Publication: Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
American Medical Association (AMA)
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Weng, Qing Yu, Adam B. Raff, Jeffrey M. Cohen, Nicole Gunasekera, Jean-Phillip Okhovat, Priyanka Vedak, Cara Joyce, Daniela Kroshinsky, and Arash Mostaghimi. 2017. “Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis.” JAMA Dermatology 153 (2) (February 1): 141. doi:10.1001/jamadermatol.2016.3816.
Research Data
Abstract
Question What is the national health care burden of misdiagnosed lower extremity cellulitis in patients admitted to the hospital from the emergency department?
Findings In this cross-sectional study that included 259 patients, 30% were misdiagnosed with cellulitis, of which 85% did not require hospitalization and 92% received unnecessary antibiotics. Combining these findings with previously published data, cost estimates, and and projections indicate that cellulitis misdiagnosis leads to 50 000 to 130 000 unnecessary hospitalizations in the United States and $195 million to $515 million in avoidable health care spending annually.
Meaning Misdiagnosis of lower extremity cellulitis is common and may lead to unnecessary patient morbidity and considerable health care spending.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service